Jpmorgan Chase & Co »

Werewolf Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $319 83 3.86
2023-09-30 $1.6k 748 2.14
2023-06-30 $2.3k 748 3.05
2023-03-31 $2.0k 748 2.67
2022-12-31 $2.0k 748 2.67
2022-06-30 $14k 3.7k 3.67
2022-03-31 $68k 16k 4.36
2021-12-31 $334k 28k 11.90